Cat1 forms filament networks to degrade NAD + during the type III CRISPR-Cas antiviral response
Science · 12.06.2025 · 388 (6752)
DOI: 10.1126/science.adv9045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 12.06.2025. Verfasst von Christian F Baca und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Bacteriology, The Rockefeller University, New York, NY, USA. Hauptthemen laut MEDLINE: CRISPR-Associated Proteins, CRISPR-Cas Systems, NAD, Chloroflexi. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NCI NIH HHS, Howard Hughes Medical Institute.
Abstract (Originalsprache)
Type III CRISPR-Cas systems defend against viral infection in prokaryotes by using an RNA-guided complex that recognizes foreign transcripts and synthesizes cyclic oligoadenylate (cOA) messengers to activate CRISPR-associated Rossmann-fold (CARF) immune effectors. In this study, we investigated a protein containing a CARF domain–fused Toll/interleukin-1 receptor (TIR) domain, Cat1. We found that Cat1 provides immunity by cleaving and depleting oxidized nicotinamide adenine dinucleotide (NAD + ) molecules from the infected host, inducing a growth arrest that prevents viral propagation. Cat1 forms dimers that stack upon each other to generate long filaments that are maintained by bound cOA ligands, with stacked TIR domains forming the NAD + cleavage catalytic sites. Furthermore, Cat1 filaments assemble into distinct trigonal and pentagonal networks that enhance NAD + degradation. Cat1 presents an unprecedented chemistry and higher-order protein assembly for the CRISPR-Cas response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Bacteriology, The Rockefeller University, New York, NY, USA.
- Tri-Institutional PhD Program in Chemical Biology, Weill Cornell Medical College, Rockefeller University and Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Structural Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Howard Hughes Medical Institute, The Rockefeller University, New York, NY, USA.
ORCID-Profile: Christian F Baca, Puja Majumder, James H Hickling, Dinshaw J Patel, Luciano A Marraffini
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
- Howard Hughes Medical Institute
- NIAID NIH HHS
Zitieren
APA
Baca, C. F., Majumder, P., Hickling, J. H., Patel, D. J., & Marraffini, L. A. (2025). Cat1 forms filament networks to degrade NAD + during the type III CRISPR-Cas antiviral response. Science, 388(6752). https://doi.org/10.1126/science.adv9045
Vancouver
Baca CF, Majumder P, Hickling JH, Patel DJ, Marraffini LA. Cat1 forms filament networks to degrade NAD + during the type III CRISPR-Cas antiviral response. Science. 2025;388(6752). doi:10.1126/science.adv9045
BibTeX
@article{Baca2025,
author = {Baca, Christian F and Majumder, Puja and Hickling, James H and Patel, Dinshaw J and Marraffini, Luciano A},
title = {Cat1 forms filament networks to degrade NAD + during the type III CRISPR-Cas antiviral response},
journal = {Science},
year = {2025},
volume = {388},
number = {6752},
doi = {10.1126/science.adv9045}
}
EUVIMED